🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
The present study has 5 parts. In Parts A and A1, the dose of intravenous (...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-04
Trial ID
NCT01295827
Treatments Being Tested
The objective of this study is to assess the tolerability, safety, and effi...
Status
Recruiting
Location
Sibley Memorial Hospital
Start Date
2023-03-03
Trial ID
NCT05768919
Treatments Being Tested
This phase II trial studies the side effects and best dose of ruxolitinib p...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2015-07-15
Trial ID
NCT02420717
This phase I/II trial studies the effect of DS-1594b with or without azacit...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-03-25
Trial ID
NCT04752163
This phase I/II trial studies the side effects and best dose of nivolumab a...
Status
Suspended
Location
Northwestern University
Start Date
2018-11-20
Trial ID
NCT03704714
Novel treatment modalities like targeted therapies and Immune checkpoint in...
Status
Unknown
Location
European Institute of oncology
Start Date
2022-07-08
Trial ID
NCT06321640
This is a 2 part Phase I/II clinical trial evaluating the safety, tolerabil...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2018-05-29
Trial ID
NCT03490292
Treatments Being Tested
This phase II/III trial tests adding glofitamab to standard of care chemoim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-30
Trial ID
NCT07724457
Treatments Being Tested
This phase I trial studies the side effects, best way to give, and the best...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2003-04
Trial ID
NCT00058227
Treatments Being Tested